This finding demonstrated that CAP may activate the TRPV1 channel to direct insulin signaling in the brain and treat diabetes and obesity by lowering blood sugar and improving insulin sensitivity (Liang et al., 2021). This evidence concerns the gene INS and obesity disorder.